Stock Yards Bank & Trust’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,168
Closed -$116K 403
2023
Q1
$116K Sell
10,168
-252
-2% -$3.12K ﹤0.01% 398
2022
Q4
$130K Buy
+10,420
New +$133K 0.01% 401
2021
Q4
Sell
-12,183
Closed -$179K 290
2021
Q3
$179K Sell
12,183
-505
-4% -$8.53K 0.01% 237
2021
Q2
$231K Buy
12,688
+505
+4% +$8.99K 0.01% 228
2021
Q1
$211K Hold
12,183
0.01% 235
2020
Q4
$212K Sell
12,183
-2,246
-16% -$35.8K 0.02% 225
2020
Q3
$199K Hold
14,429
0.02% 221
2020
Q2
$208K Hold
14,429
0.02% 215
2020
Q1
$158K Sell
14,429
-140
-1% -$2.58K 0.02% 206
2019
Q4
$311K Sell
14,569
-62
-0.4% -$1.39K 0.03% 195
2019
Q3
$336K Hold
14,631
0.03% 176
2019
Q2
$288K Hold
14,631
0.03% 191
2019
Q1
$285K Sell
14,631
-579
-4% -$11K 0.03% 194
2018
Q4
$251K Sell
15,210
-65
-0.4% -$1.31K 0.03% 189
2018
Q3
$354K Buy
15,275
+579
+4% +$13.1K 0.04% 170
2018
Q2
$319K Hold
14,696
0.04% 169
2018
Q1
$259K Buy
+14,696
New +$259K 0.03% 196

Other funds holding SBRA

Stock Yards Bank & Trust's SBRA Position: Q2 2023 in Review

Stock Yards Bank & Trust sold out of Sabra Healthcare REIT (SBRA) in Q2 2023, closing a stake of 10,168 shares — an estimated $116K sold.

Stock Yards Bank & Trust first reported a position in SBRA in Q1 2018 and held it in 17 quarters. The position peaked at $354K in Q3 2018. 325 funds tracked by Wall St. Rank hold SBRA as of Q2 2023.

  • Stock Yards Bank & Trust reported no remaining Sabra Healthcare REIT position as of Q2 2023 after selling out during the quarter.
  • Stock Yards Bank & Trust sold 10,168 Sabra Healthcare REIT shares in Q2 2023, an estimated $116K.
  • Stock Yards Bank & Trust first reported a position in Sabra Healthcare REIT in Q1 2018 and held it in 17 quarters.
  • Stock Yards Bank & Trust's Sabra Healthcare REIT position peaked at $354K in Q3 2018.
  • 325 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2023.

Based on Stock Yards Bank & Trust's 13F filing for Q2 2023, filed 2 Aug 2023.